JBTM
JBT Marel Corporation
JBTM has slightly lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over JBTM overall, supported by stronger valuation and stronger modeled upside.
JBTM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
JBTM's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
JBTM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $41.41 | -67% |
| Forward | 14x | $125 | — |
| Fair | 28x | $104 | -17% |
| Current | 33x | $125 | — |
| Expensive | 41x | $153 | +22% |
Historical ranges are pointers, not guarantees.
JBTM's PE is in its expensive range at 33x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over JBTM in the historical PE scenario, which offers more potential upside but is not a forecast.
JBTM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect JBTM's earnings to grow and its profitability to improve, with its revenue holding steady.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
VRT has the edge over JBTM on the outlook, with more favorable revenue expectations.
JBTM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.08 | +140% |
| Q3 2026 | $3.78 | +$6.02 |
| Q2 2026 | $3.70 | +$5.99 |
| Q1 2026 | $3.23 | +$4.64 |
| Q4 2025 | -$0.98 | -137% |
| Q3 2025 | -$2.24 | -142% |
| Q2 2025 | -$2.29 | -112% |
| Q1 2025 | -$1.41 | -108% |
| Q4 2024 | $2.65 | -86% |
JBTM has returned to profit: it earned $3.78 per share over the past year, after losing money the year before.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over JBTM on earnings, with more consistent year-over-year improvement.
JBTM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $994M | -0.7% |
| Q2 2026 | $981M | +4.9% |
| Q1 2026 | $936M | +9.6% |
| Q4 2025 | $1B | +116% |
| Q3 2025 | $1B | +121% |
| Q2 2025 | $934.8M | +132% |
| Q1 2025 | $854.1M | +118% |
| Q4 2024 | $467.6M | +5.2% |
JBTM's revenue is growing: $994M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | -0.1 points |
| Q2 2026 | 4.7% | -0.5 points |
| Q1 2026 | 7.3% | +11 points |
| Q4 2025 | 7.2% | +3.8 points |
| Q3 2025 | 10% | -0.1 points |
| Q2 2025 | 5.2% | -1.5 points |
| Q1 2025 | -3.9% | -11 points |
| Q4 2024 | 3.4% | -9.6 points |
JBTM's operating margin was 10% last quarter, about level with the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT's revenue has grown year over year every quarter since late 2020: $4.3B last quarter, up 61% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over JBTM on profitability, with a higher operating margin.
JBTM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $73M | +29% |
| Q2 2026 | $77M | -8% |
| Q1 2026 | $93M | +546% |
| Q4 2025 | $83.5M | -30% |
| Q3 2025 | $56.5M | -13% |
| Q2 2025 | $83.7M | +654% |
| Q1 2025 | $14.4M | +$14.5M |
| Q4 2024 | $118.7M | +$149M |
JBTM generated $327M in free cash flow over the past year, up 19% from the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over JBTM on cash flow, with more consistent year-over-year improvement.
JBTM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -600K shares |
| 1 year | -1.3% | -700K shares |
| 3 years | +61% | +19.5M shares |
| 5 years | +61% | +19.5M shares |
| Available history | +61% | +19.5M shares |
JBTM has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $94M |
| Q4 2023 | $5.1M |
| Q3 2023 | — |
| Q4 2022 | $4.9M |
| Q3 2022 | $500,000 |
| Q4 2019 | — |
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
JBTM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.6x | Very low |
| Q2 2024 | 1.0x | Very low |
| Q1 2024 | 0.9x | Very low |
| Q4 2023 | 0.8x | Very low |
| Q3 2023 | 1.2x | Healthy |
| Q2 2023 | 4.1x | High |
| Q1 2023 | 4.2x | High |
JBTM's net debt is less than a year of its operating earnings (EBITDA).
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has more cash than debt.
JBTM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.6 | Neutral |
| Stochastic | 51.7 | Neutral |
JBTM's weekly RSI is 53 (neutral) and its Stochastic is 52 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
JBTM PE vs Industrials Sector
| Metric | JBTM | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 24x | 38% above |
| PE % | 73 | 58 | 15 pts above |
JBTM has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
JBTM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $112.7 | 11% above |
| 20 week MA | $120.7 | 3.7% above |
| 50 week MA | $133.2 | 6% below |
| 100 week MA | $130.0 | 3.7% below |
| 200 week MA | $117.0 | 7% above |
JBTM has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
JBTM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $114.8 | $117.8 | +2.6% |
| 2021 | $117.8 | $153.0 | +30% |
| 2022 | $153.0 | $89.2 | -42% |
| 2023 | $89.2 | $99.5 | +11% |
| 2024 | $99.5 | $128.4 | +29% |
| 2025 | $128.4 | $155.1 | +21% |
| 2026 YTD | $155.1 | $125.2 | -19% |
JBTM has finished higher in five of the last six years. It's down 19% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over JBTM on returns for 2026, with the stronger performance.